The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
American Technion Society – New England Presents Boston Business Council Meeting With Maya Kaduri ’17, M.S.’19 and Dean Zadok ’19 In February 2022, ATS New England and the Boston Business Council joined forces for an interactive discussion with Maya Kaduri ’17, M.S.’19, a Ph.D. candidate in the Wolfson Faculty of Chemical Engineering, and Dean Zadok ’19, a master’s student […]
Pictured above: Dr. Hanan Abumanhal Masarweh and Prof. Avi Schroeder Researcher behind the discovery is Dr. Hanan Abumanhal Masarweh, of the Russell Berrie Nanotechnology Institute at the Technion. She received her Ph.D. for her research under the supervision of Professor Avi Schroeder of the Technion’s Wolfson Faculty of Chemical Engineering. Baking soda, that simple product available at any supermarket, could revolutionize breast cancer treatment, according to Technion researchers who have found that this substance changes the acidity of the cancerous tumor and thus increases the efficacy of chemotherapy. The researcher behind the intriguing study is Dr. Hanan Abumanhal Masarweh. In…
People who have just learned they have a tumor face heart-wrenching questions such as: is it cancerous? Will it spread? Metastasis, the spread of cancer cells from the primary tumor to new areas of the body, is responsible for an alarming 90% of cancer-related deaths. But knowing the risk of metastasis early on can help determine the most effective treatment and improve the patient’s outcome. A research team led by Technion Professor Daphne Weihs of the Faculty of Biomedical Engineering has developed and tested a biomechanical technology to predict whether a tumor is cancerous, and if so, the likelihood of…
What if the treatment for your cancer was as unique as you are? That’s the promise of a new technology developed at the Technion by doctoral students Gil Shamai and Ron Slossberg and Professor Ron Kimmel of the Technion Faculty of Computer Science, in collaboration with Dr. Yoav Binenbaum of Ichilov Hospital and Professor Ziv Gil of Rambam Medical Center. The deep learning–based method for mapping critical receptors on cancer cells is expected to lead to better, more personalized cancer treatment. The technology extracts molecular information from digital biopsy images that underwent hematoxylin and eosin (H&E) staining. H&E staining allows…